Select text to enable text to speech.

OLISENS-ANIRIDIA

Uniklinik Köln, Cologne, Germany

Aniridia-associated keratopathy

June 2026 - December 2026

Status of the study

0 / 20 patients included

Indication: Pathological corneal neovascularization associated with Aniridia-Associated Keratopathy (AAK).

A single-center study evaluating the efficacy and safety of Olisens eye drops.

Patient Information Sheet and Informed Consent Form for Participation in the Study

Want to participate? Please contact augenklinik-studien@uk-koeln.de

Interested in Restore vision?

Restore vision, is a consumer-oriented non-profit organisation, founded to make the science behind food and health more accessible and easier to understand among the public.